Issue 11, Quarter 1, 2025 of the Change Maker Chronicle

The Spring edition of The Change Maker Chronicle is here!

We’re taking you to the NEXT LEVEL with bold steps, real stories, and a behind-the-scenes look at what’s NEXT in the fight to end drug shortages. In this issue, you’ll hear from some of our Shortage Warriors and experience the powerful impact their voices have on the community. From milestone wins to what’s ahead in Q2, see how we continue to LEVEL UP our mission—together.

👉 Read the Changemaker Chronicle: Issue 11, Quarter 1, 2025

This is what is possible when Change Makers like you join us in the NEXT LEVEL of the fight to end drug shortages!

#NextLevel2025
#LevelUp
#EndingDrugShortagesNOW
#ChangeMakerChronicle

Local woman credits nonprofit amid I.V. fluid shortage

Angels for Change was recently featured in a powerful News10 story highlighting our mission to end drug shortages and the critical impact our work has on patients across the country. The piece shares the story of Brooke, a patient in Warrensburg, N.Y., who faced a terrifying delay in receiving her IV fluid treatments due to a national shortage.

When traditional supply chain solutions failed, Brooke and her mother, Cathy, turned to Angels for Change. Through our national network and rapid advocacy efforts, we were able to help locate the essential IV fluids she needed to continue her care, demonstrating once again how patient-centered advocacy can make a life-saving difference.

Behind every shortage is a real person with real needs. Thank you, News10, for raising awareness around the drug shortage crisis. We are committed to advocating for patients, raising awareness, and building a more resilient and equitable pharmaceutical supply chain.

Watch the news segment below and read the news article here.

Angels for Change Launches Project GOLD

Angels for Change Launches Project GOLD

Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and  pharmaceutical and medtech manufacturer Fresenius Kabi.

Angels for Change (A4C) announces 2024 Change Maker of the Year Award

Angels for Change (A4C) announces 2024 Change Maker of the Year Award

Angels for Change (A4C) announces its 2024 Change Maker of the Year Award , Lindsey Thomas, Senior Vice President of Marketing at Fresenius Kabi USA. Lindsey was recognized for her exceptional leadership, collaborative spirit, and unwavering commitment to patient care, particularly in addressing the critical  chemotherapy drug shortages during  2023 and 2024.

Angels for Change participates in Milken Future of Health Summit

Angels for Change participates in Milken Future of Health Summit

How Pharmaceutical Supply Chain Advancements are Meeting the Moment and Beyond panel at Milken Institute Future of Health Summit, moderated by Sarah Karlin-Smith from Citeline, with Panelists Laura Bray from Angels for Change, Shamiram Feinglass MD, MPH from Manatt, Phelps & Phillips, LLP, Kirk Kaminsky from McKesson and Vimala Raghavendran from US Pharmacopeia.

Angels for Change Announces Key Update on Project PROTECT Grant Award: Fagron, Inc. to Supply Critical Dextrose Amid Predicted Shortages

Angels for Change Announces Key Update on Project PROTECT Grant Award: Fagron, Inc. to Supply Critical Dextrose Amid Predicted Shortages

Angels for Change is proud to announce a significant milestone in Project PROTECT. Fagron Sterile Services US (FSS), a recipient of the 2023 Project PROTECT grant and a leader 503B outsourcing, has completed the Preparation and Protective phases for preservative-free Dextrose 70% injection solution. The significance of this achievement is highlighted by the recent flooding at Baxter's North Cove manufacturing site due to Hurricane Helene, which prompted the U.S. Food and Drug Administration to include Dextrose on its drug shortage list as of October 12, 2024. The strategic preparations made through Project PROTECT, Dextrose will remain accessible to vulnerable patients, especially PICU and NICU babies, amid anticipated supply chain disruptions.